The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population

NCT03057457 · clinicaltrials.gov ↗
UNKNOWN
Status
530
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BioPorto Diagnostics